FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:283-287 August 3, 1995 Number 5 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kanz, L. PubMed Citation

ABSTRACT

Background Autologous peripheral-blood progenitor cells can restore hematopoiesis after high-dose chemotherapy in patients with solid tumors or hematologic cancers. We investigated the ability of peripheral-blood progenitor cells generated ex vivo to restore hematopoiesis in patients with cancer who have undergone high-dose chemotherapy.

Methods Ten patients who had received high-dose chemotherapy were given transplants of autologous progenitor cells that had been generated ex vivo. We used 11 million CD34+ hematopoietic progenitor cells as the starting population for the cell growth. This number corresponds to less than 10 percent of the usual preparation of peripheral-blood CD34+ mononuclear cells used in leukapheresis. The CD34+ cells were grown in medium containing autologous plasma, recombinant human stem-cell factor, interleukin-1, interleukin-3, interleukin-6, and erythropoietin.

Results No toxic effects were observed with the infusion of the generated cells. The cells promoted a rapid and sustained hematopoietic recovery when transplanted after treatment with high-dose etoposide (1500 mg per square meter of body-surface area), ifosfamide (12 g per square meter), carboplatin (750 mg per square meter), and epirubicin (150 mg per square meter). The pattern of hematopoietic reconstitution was identical to that in historical controls treated with unseparated mononuclear cells or positively selected CD34+ cells.

Conclusions A small number of peripheral-blood CD34+ cells, when grown ex vivo, can supply a population of hematopoietic precursors that have the ability to restore blood formation in patients treated with high doses of chemotherapy. This method, which requires only a small volume of the patient's blood, may reduce the risk of tumor-cell contamination, circumvent the need for leukapheresis, and allow repeated cycles of high-dose chemotherapy.

Source Information

From the Albert-Ludwigs University Medical Center, Department of Hematology/Oncology, Freiburg, Germany (W.B., R.M., L.K.); and the CellPro Corporation, Bothell, Wash. (S.H., R.J.B.).

Address reprint requests to Dr. Kanz at the University Medical Center, Department of Hematology/Oncology, Otfried-Müller Str. 10, 72076 Tübingen, Germany.

Full Text of this Article

Related Letters:

Hematopoietic Reconstitution with Autologous Stem Cells
Juliusson G., Brugger W., Kanz L.
Extract | Full Text  
N Engl J Med 1996; 334:271-272, Jan 25, 1996. Correspondence

This article has been cited by other articles:

• Huang, L. T., Paredes, C. J., Papoutsakis, E. T., Miller, W. M. (2007). Gene expression analysis illuminates the transcriptional programs underlying the functional activity of ex vivo-expanded granulocytes. Physiol. Genomics 31: 114-125 [Abstract] [Full Text]  
• Matsumoto, T., Kawamoto, A., Kuroda, R., Ishikawa, M., Mifune, Y., Iwasaki, H., Miwa, M., Horii, M., Hayashi, S., Oyamada, A., Nishimura, H., Murasawa, S., Doita, M., Kurosaka, M., Asahara, T. (2006). Therapeutic Potential of Vasculogenesis and Osteogenesis Promoted by Peripheral Blood CD34-Positive Cells for Functional Bone Healing. Am. J. Pathol. 169: 1440-1457 [Abstract] [Full Text]  
• Iwasaki, H., Kawamoto, A., Ishikawa, M., Oyamada, A., Nakamori, S., Nishimura, H., Sadamoto, K., Horii, M., Matsumoto, T., Murasawa, S., Shibata, T., Suehiro, S., Asahara, T. (2006). Dose-Dependent Contribution of CD34-Positive Cell Transplantation to Concurrent Vasculogenesis and Cardiomyogenesis for Functional Regenerative Recovery After Myocardial Infarction. Circulation 113: 1311-1325 [Abstract] [Full Text]  
• Murasawa, S., Asahara, T. (2005). Endothelial Progenitor Cells for Vasculogenesis. Physiology 20: 36-42 [Abstract] [Full Text]  
• Asahara, T., Kawamoto, A. (2004). Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 287: C572-C579 [Abstract] [Full Text]  
• Balducci, E., Azzarello, G., Valenti, M. T., Capuzzo, G. M., Pappagallo, G. L., Pilotti, I., Ausoni, S., Bari, M., Rosetti, F., Sartori, D., Ciappa, A., Porcellini, A., Vinante, O. (2003). The Impact of Progenitor Enrichment, Serum, and Cytokines on the Ex Vivo Expansion of Mobilized Peripheral Blood Stem Cells: A Controlled Trial. Stem Cells 21: 33-40 [Abstract] [Full Text]  
• Fiuza, C., Salcedo, M., Clemente, G., Tellado, J. M. (2002). Granulocyte Colony-Stimulating Factor Improves Deficient In Vitro Neutrophil Transendothelial Migration in Patients with Advanced Liver Disease. CVI 9: 433-439 [Abstract] [Full Text]  
• Drouet, M., Herodin, F., Norol, F., Mourcin, F., Mayol, J.F. (2001). Cell Cycle Activation of Peripheral Blood Stem and Progenitor Cells Expanded Ex Vivo with SCF, FLT-3 Ligand, TPO, and IL-3 Results in Accelerated Granulocyte Recovery in a Baboon Model of Autologous Transplantation but G0/G1 and S/G2/M Graft Cell Content Does Not Correlate with Tranplantability. Stem Cells 19: 436-442 [Abstract] [Full Text]  
• Kanz, L., Brugger, W. (2001). Retraction: Reconstitution of Hematopoiesis after High-Dose Chemotherapy by Autologous Progenitor Cells Generated ex Vivo. NEJM 345: 64-64 [Full Text]  
• Kimura, T., Wang, J., Minamiguchi, H., Fujiki, H., Harada, S., Okuda, K., Kaneko, H., Yokota, S., Yasukawa, K., Abe, T., Sonoda, Y. (2000). Signal through gp130 Activated by Soluble Interleukin (IL)-6 Receptor (R) and IL-6 or IL-6R/IL-6 Fusion Protein Enhances Ex Vivo Expansion of Human Peripheral Blood-Derived Hematopoietic Progenitors. Stem Cells 18: 444-452 [Abstract] [Full Text]  
• McNiece, I., Jones, R., Bearman, S. I., Cagnoni, P., Nieto, Y., Franklin, W., Ryder, J., Steele, A., Stoltz, J., Russell, P., McDermitt, J., Hogan, C., Murphy, J., Shpall, E. J. (2000). Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 96: 3001-3007 [Abstract] [Full Text]  
• Crosby, J. R., Kaminski, W. E., Schatteman, G., Martin, P. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F. (2000). Endothelial Cells of Hematopoietic Origin Make a Significant Contribution to Adult Blood Vessel Formation. Circ. Res. 87: 728-730 [Abstract] [Full Text]  
• Paquette, R. L., Dergham, S. T., Karpf, E., Wang, H.-J., Slamon, D. J., Souza, L., Glaspy, J. A. (2000). Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 96: 2385-2390 [Abstract] [Full Text]  
• Crooks, G. M., Hao, Q.-L., Petersen, D., Barsky, L. W., Bockstoce, D. (2000). IL-3 Increases Production of B Lymphoid Progenitors from Human CD34+CD38- Cells. J. Immunol. 165: 2382-2389 [Abstract] [Full Text]  
• Szilvassy, S. J., Meyerrose, T. E., Grimes, B. (2000). Effects of cell cycle activation on the short-term engraftment properties of ex vivo expanded murine hematopoietic cells. Blood 95: 2829-2837 [Abstract] [Full Text]  
• Stiff, P., Chen, B., Franklin, W., Oldenberg, D., Hsi, E., Bayer, R., Shpall, E., Douville, J., Mandalam, R., Malhotra, D., Muller, T., Armstrong, R. D., Smith, A. (2000). Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 95: 2169-2174 [Abstract] [Full Text]  
• Vogel, W., Scheding, S., Kanz, L., Brugger, W. (2000). Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC). Stem Cells 18: 87-92 [Abstract] [Full Text]  
• Holmberg, L. A., Boeckh, M., Hooper, H., Leisenring, W., Rowley, S., Heimfeld, S., Press, O., Maloney, D. G., McSweeney, P., Corey, L., Maziarz, R. T., Appelbaum, F. R., Bensinger, W. (1999). Increased Incidence of Cytomegalovirus Disease After Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation. Blood 94: 4029-4035 [Abstract] [Full Text]  
• Ramsfjell, V., Bryder, D., Bjorgvinsdottir, H., Kornfalt, S., Nilsson, L., Borge, O. J., Jacobsen, S. E.W. (1999). Distinct Requirements for Optimal Growth and In Vitro Expansion of Human CD34+CD38- Bone Marrow Long-Term Culture-Initiating Cells (LTC-IC), Extended LTC-IC, and Murine In Vivo Long-Term Reconstituting Stem Cells. Blood 94: 4093-4102 [Abstract] [Full Text]  
• Huang, S., Chen, Z., Yu, J. F., Young, D., Bashey, A., Ho, A. D., Law, P. (1999). Correlation Between IL-3 Receptor Expression and Growth Potential of Human CD34+ Hematopoietic Cells from Different Tissues. Stem Cells 17: 265-272 [Abstract] [Full Text]  
• Drouet, M., Mathieu, J., Grenier, N., Multon, E., Sotto, J.-J., Herodin, F. (1999). The Reduction of In Vitro Radiation-Induced Fas-Related Apoptosis in CD34+ Progenitor Cells by SCF, FLT-3 Ligand, TPO, and IL-3 in Combination Resulted in CD34+ Cell Proliferation and Differentiation. Stem Cells 17: 273-285 [Abstract] [Full Text]  
• Shih, C.-C., Hu, M. C.-T., Hu, J., Medeiros, J., Forman, S. J. (1999). Long-Term Ex Vivo Maintenance and Expansion of Transplantable Human Hematopoietic Stem Cells. Blood 94: 1623-1636 [Abstract] [Full Text]  
• Andrews, R. G., Briddell, R. A., Hill, R., Gough, M., McNiece, I. K. (1999). Engraftment of Primates with G-CSF Mobilized Peripheral Blood CD34+ Progenitor Cells Expanded in G-CSF, SCF and MGDF Decreases the Duration and Severity of Neutropenia. Stem Cells 17: 210-218 [Abstract] [Full Text]  
• Brandt, J. E., Bartholomew, A. M., Fortman, J. D., Nelson, M. C., Bruno, E., Chen, L. M., Turian, J. V., Davis, T. A., Chute, J. P., Hoffman, R. (1999). Ex Vivo Expansion of Autologous Bone Marrow CD34+ Cells With Porcine Microvascular Endothelial Cells Results in a Graft Capable of Rescuing Lethally Irradiated Baboons. Blood 94: 106-113 [Abstract] [Full Text]  
• Erben, U., Thiel, E., Notter, M. (1999). Differential Effects of a Stem Cell Factor-Immunoglobulin Fusion Protein on Malignant and Normal Hematopoietic Cells. Cancer Res. 59: 2924-2930 [Abstract] [Full Text]  
• Möbest, D., Goan, S.-R., Junghahn, I., Winkler, J., Fichtner, I., Becker, M., de Lima-Hahn, E., Mertelsmann, R., Henschler, R. (1999). Differential Kinetics of Primitive Hematopoietic Cells Assayed In Vitro and In Vivo During Serum-Free Suspension Culture of CD34+ Blood Progenitor Cells. Stem Cells 17: 152-161 [Abstract] [Full Text]  
• Guenechea, G., Segovia, J.C., Albella, B., Lamana, M., Ramirez, M., Regidor, C., Fernandez, M.N., Bueren, J.A. (1999). Delayed Engraftment of Nonobese Diabetic/Severe Combined Immunodeficient Mice Transplanted With Ex Vivo-Expanded Human CD34+ Cord Blood Cells. Blood 93: 1097-1105 [Abstract] [Full Text]  
• Spyridonidis, A., Bernhardt, W., Behringer, D., Kohler, G., Azemar, M., Pflug, A., Henschler, R. (1999). Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+ Blood Progenitor Cells. Blood 93: 746-755 [Abstract] [Full Text]  
• Goff, J. P., Shields, D. S., Greenberger, J. S. (1998). Influence of Cytokines on the Growth Kinetics and Immunophenotype of Daughter Cells Resulting From the First Division of Single CD34+Thy-1+lin- Cells. Blood 92: 4098-4107 [Abstract] [Full Text]  
• Peters, R., Leyvraz, S., Perey, L. (1998). Apoptotic Regulation in Primitive Hematopoietic Precursors. Blood 92: 2041-2052 [Abstract] [Full Text]  
• Tisdale, J.F., Hanazono, Y., Sellers, S.E., Agricola, B.A., Metzger, M.E., Donahue, R.E., Dunbar, C.E. (1998). Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating Ability. Blood 92: 1131-1141 [Abstract] [Full Text]  
• Matsunaga, T., Hirayama, F., Yonemura, Y., Murray, R., Ogawa, M. (1998). Negative Regulation by Interleukin-3 (IL-3) of Mouse Early B-Cell Progenitors and Stem Cells in Culture: Transduction of the Negative Signals by beta c and beta IL-3 Proteins of IL-3 Receptor and Absence of Negative Regulation by Granulocyte-Macrophage Colony-Stimulating Factor. Blood 92: 901-907 [Abstract] [Full Text]  
• Abkowitz, J. L., Taboada, M. R., Sabo, K. M., Shelton, G. H. (1998). The Ex Vivo Expansion of Feline Marrow Cells Leads to Increased Numbers of BFU-E and CFU-GM but a Loss of Reconstituting Ability. Stem Cells 16: 288-293 [Abstract] [Full Text]  
• Takahashi, T., Yamada, K., Tanaka, T., Kumano, K., Kurokawa, M., Takahashi, T., Hirano, N., Honda, H., Chiba, S., Tsuji, K., Yazaki, Y., Nakahata, T., Hirai, H. (1998). A Potential Molecular Approach to Ex Vivo Hematopoietic Expansion With Recombinant Epidermal Growth Factor Receptor-Expressing Adenovirus Vector. Blood 91: 4509-4515 [Abstract] [Full Text]  
• Shimizu, Y., Ogawa, M., Kobayashi, M., Almeida-Porada, G., Zanjani, E. D. (1998). Engraftment of Cultured Human Hematopoietic Cells in Sheep. Blood 91: 3688-3692 [Abstract] [Full Text]  
• Spyridonidis, A., Schmidt, M., Bernhardt, W., Papadimitriou, A., Azemar, M., Wels, W., Groner, B., Henschler, R. (1998). Purging of Mammary Carcinoma Cells During Ex Vivo Culture of CD34+ Hematopoietic Progenitor Cells With Recombinant Immunotoxins. Blood 91: 1820-1827 [Abstract] [Full Text]  
• Zijlmans, J. M. J. M., Visser, J. W. M., Laterveer, L., Kleiverda, K., Heemskerk, D. P. M., Kluin, P. M., Willemze, R., Fibbe, W. E. (1998). The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95: 725-729 [Abstract] [Full Text]  
• Breems, D. A., Blokland, E. A.W., Siebel, K. E., Mayen, A. E.M., Engels, L. J.A., Ploemacher, R. E. (1998). Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells. Blood 91: 111-117 [Abstract] [Full Text]  
• Sato, T., Selleri, C., Young, N. S., Maciejewski, J. P. (1997). Inhibition of Interferon Regulatory Factor-1 Expression Results in Predominance of Cell Growth Stimulatory Effects of Interferon-gamma Due to Phosphorylation of Stat1 and Stat3. Blood 90: 4749-4758 [Abstract] [Full Text]  
• Shpall, E. J., LeMaistre, C. F., Holland, K., Ball, E., Jones, R. B., Saral, R., Jacobs, C., Heimfeld, S., Berenson, R., Champlin, R. (1997). A Prospective Randomized Trial of Buffy Coat Versus CD34-Selected Autologous Bone Marrow Support in High-Risk Breast Cancer Patients Receiving High-Dose Chemotherapy. Blood 90: 4313-4320 [Abstract] [Full Text]  
• Humeau, L., Chabannon, C., Firpo, M. T., Mannoni, P., Bagnis, C., Roncarolo, M.-G., Namikawa, R. (1997). Successful Reconstitution of Human Hematopoiesis in the SCID-hu Mouse by Genetically Modified, Highly Enriched Progenitors Isolated From Fetal Liver. Blood 90: 3496-3506 [Abstract] [Full Text]  
• Eder, M., Geissler, G., Ganser, A. (1997). IL-3 in the Clinic. Stem Cells 15: 327-333 [Abstract] [Full Text]  
• Bhatia, M., Bonnet, D., Kapp, U., Wang, J. C.Y., Murdoch, B., Dick, J. E. (1997). Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture. J. Exp. Med. 186: 619-624 [Abstract] [Full Text]  
• Broudy, V. C. (1997). Stem Cell Factor and Hematopoiesis. Blood 90: 1345-1364 [Full Text]  
• Paulus, U., Dreger, P., Viehmann, K., Neuhoff, N. v., Schmitz, N. (1997). Purging Peripheral Blood Progenitor Cell Grafts from Lymphoma Cells: Quantitative Comparison of Immunomagnetic CD34+ Selection Systems. Stem Cells 15: 297-304 [Abstract] [Full Text]  
• Koller, M. R., Manchel, I., Palsson, B. O. (1997). Importance of Parenchymal:Stromal Cell Ratio for the Ex Vivo Reconstitution of Human Hematopoiesis. Stem Cells 15: 305-313 [Abstract] [Full Text]  
• Albella, B., Segovia, J. C., Bueren, J. A. (1997). Does the Granulocyte-Macrophage Colony-Forming Unit Content in Ex Vivo-Expanded Grafts Predict the Recovery of the Recipient Leukocytes?. Blood 90: 464-470 [Abstract] [Full Text]  
• LaIuppa, J. A., Papoutsakis, E. T., Miller, W. M. (1997). Evaluation of Cytokines for Expansion of the Megakaryocyte and Granulocyte Lineages. Stem Cells 15: 198-206 [Abstract] [Full Text]  
• Brown, R. L., Xu, F. S., Dusing, S. K., Li, Q., Fischer, R., Patchen, M. (1997). Serum-Free Culture Conditions for Cells Capable of Producing Long-Term Survival in Lethally Irradiated Mice. Stem Cells 15: 237-245 [Abstract] [Full Text]  
• Bertolini, F., Battaglia, M., Pedrazzoli, P., Antonio Da Prada, G., Lanza, A., Soligo, D., Caneva, L., Sarina, B., Murphy, S., Thomas, T., Robustelli della Cuna, G. (1997). Megakaryocytic Progenitors Can Be Generated Ex Vivo and Safely Administered to Autologous Peripheral Blood Progenitor Cell Transplant Recipients. Blood 89: 2679-2688 [Abstract] [Full Text]  
• To, L.B., Haylock, D.N., Simmons, P.J., Juttner, C.A. (1997). The Biology and Clinical Uses of Blood Stem Cells. Blood 89: 2233-2258 [Full Text]  
• Testa, U., Martucci, R., Scambia, G., Benedetti Panici, P., Mancuso, S., Camagna, A., Mastroberardino, G., Pierelli, L., Menichella, G., Peschle, C. (1997). Autologous Stem Cell Transplantation: Exogenous Granulocyte Colony-Stimulating Factor or Granulocyte-Macrophage Colony-Stimulating Factor Modulate the Endogenous Cytokine Levels. Blood 89: 2615-2617 [Full Text]  
• Somlo, G., Sniecinski, I., Odom-Maryon, T., Nowicki, B., Chow, W., Hamasaki, V., Leong, L., Margolin, K., Morgan Jr, R., Raschko, J., Shibata, S., Tetef, M., Molina, A., Berenson, R.J., Forman, S.J., Doroshow, J.H. (1997). Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer. Blood 89: 1521-1528 [Abstract] [Full Text]  
• Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., Isner, J. M. (1997). Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science 275: 964-966 [Abstract] [Full Text]  
• Arseniev, L., Link, H., Hubner, G., Novotny, J., Ganser, A., Hertenstein, B. (1997). Transient Increase of Leukocytes After Transplantation of Expanded and Nonexpanded Allogeneic CD34+ Blood Cells Is of Host Origin. Blood 89: 1116-1116 [Full Text]  
• Mapara, M. Y., Korner, I. J., Hildebrandt, M., Bargou, R., Krahl, D., Reichardt, P., Dorken, B. (1997). Monitoring of Tumor Cell Purging After Highly Efficient Immunomagnetic Selection of CD34 Cells From Leukapheresis Products in Breast Cancer Patients: Comparison of Immunocytochemical Tumor Cell Staining and Reverse Transcriptase-Polymerase Chain Reaction. Blood 89: 337-344 [Abstract] [Full Text]  
• Servida, F, Soligo, D, Caneva, L, Bertolini, F, de Harven, E, Campiglio, S, Corsini, C, Deliliers, G. (1996). Functional and morphological characterization of immunomagnetically selected CD34+ hematopoietic progenitor cells. Stem Cells 14: 430-438 [Abstract]  
• Pavletic, Z. S., Armitage, J. O. (1996). Bone Marrow Transplantation for Cancer--An Update. The Oncologist 1: 159-168 [Abstract] [Full Text]  
• Juliusson, G., Brugger, W., Kanz, L. (1996). Hematopoietic Reconstitution with Autologous Stem Cells. NEJM 334: 271-272 [Full Text]  
• Kessinger, A. (1995). Circulating Stem Cells -- Waxing Hematopoietic. NEJM 333: 315-317 [Full Text]  
• Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W. M., Silver, M., Kearney, M., Li, T., Isner, J. M., Asahara, T. (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97: 3422-3427 [Abstract] [Full Text]